DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹11 Cr | ₹10 Cr | ₹14 Cr | ₹13 Cr | ₹10 Cr |
What is the latest Contingent Liabilities ratio of DR LAL PATHLABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹10 Cr |
How is Contingent Liabilities of DR LAL PATHLABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 4.99 | |
| Mar2024 | ₹10 Cr | -26.02 | |
| Mar2023 | ₹14 Cr | 3.43 | |
| Mar2022 | ₹13 Cr | 26.43 | |
| Mar2021 | ₹10 Cr | - | |
Compare Contingent Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,379.4 Cr | -1.7% | -2.4% | -2.8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹97,812.4 Cr | 0.1% | -3.9% | -1.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹92,688.1 Cr | -4.6% | -10.4% | -11.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹63,590.1 Cr | 0.1% | -4.8% | 33.5% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,623.1 Cr | -1.8% | -6.2% | 32.7% | Stock Analytics | |
| GLOBAL HEALTH | ₹27,806.4 Cr | -2.9% | -10.4% | -2.1% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -1.7% |
-2.4% |
-2.8% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses